Correlation Between Tarsus Pharmaceuticals and Metalink

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Metalink at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Metalink into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Metalink, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Metalink and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Metalink. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Metalink.

Diversification Opportunities for Tarsus Pharmaceuticals and Metalink

0.84

Correlation Coefficient

Tarsus Pharmaceuticals  Metalink

Very poor diversification

The 3 months correlation between Tarsus and Metalink is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Metalink in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Metalink and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Metalink. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Metalink has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Metalink go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Metalink

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 8.45 times more return on investment than Metalink. However, Tarsus Pharmaceuticals is 8.45 times more volatile than Metalink. It trades about 0.34 of its potential returns per unit of risk. Metalink is currently generating about 0.13 per unit of risk. If you would invest  3,321  in Tarsus Pharmaceuticals on October 7, 2024 and sell it today you would earn a total of  2,246  from holding Tarsus Pharmaceuticals or generate 67.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Metalink

Tarsus Pharmaceuticals

Risk-Adjusted Performance

26 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Metalink

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Metalink are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent essential indicators, Metalink is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Tarsus Pharmaceuticals and Metalink

The main advantage of trading using opposite Tarsus Pharmaceuticals and Metalink positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Metalink can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Metalink will offset losses from the drop in Metalink's long position.

The idea behind Tarsus Pharmaceuticals and Metalink pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.